nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—Nateglinide—type 2 diabetes mellitus	0.166	0.622	CrCtD
Trandolapril—coronary artery disease—type 2 diabetes mellitus	0.139	0.626	CtDrD
Trandolapril—Ramipril—type 2 diabetes mellitus	0.101	0.378	CrCtD
Trandolapril—ACE—type 2 diabetes mellitus	0.0874	1	CbGaD
Trandolapril—hypertension—type 2 diabetes mellitus	0.0829	0.374	CtDrD
Trandolapril—ACE—Ramipril—type 2 diabetes mellitus	0.0286	0.169	CbGbCtD
Trandolapril—ACE—Losartan—type 2 diabetes mellitus	0.0168	0.0998	CbGbCtD
Trandolapril—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0168	0.0993	CbGbCtD
Trandolapril—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0149	0.0885	CbGbCtD
Trandolapril—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0144	0.0855	CbGbCtD
Trandolapril—Mitiglinide—Nateglinide—type 2 diabetes mellitus	0.0143	0.0801	CrCrCtD
Trandolapril—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0133	0.0789	CbGbCtD
Trandolapril—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0129	0.0762	CbGbCtD
Trandolapril—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0127	0.0752	CbGbCtD
Trandolapril—Spirapril—Nateglinide—type 2 diabetes mellitus	0.0124	0.0693	CrCrCtD
Trandolapril—Lisinopril—Nateglinide—type 2 diabetes mellitus	0.0124	0.0693	CrCrCtD
Trandolapril—Cilazapril—Nateglinide—type 2 diabetes mellitus	0.0124	0.0693	CrCrCtD
Trandolapril—Ramipril—Nateglinide—type 2 diabetes mellitus	0.0116	0.065	CrCrCtD
Trandolapril—Enalapril—Nateglinide—type 2 diabetes mellitus	0.0116	0.065	CrCrCtD
Trandolapril—Perindopril—Ramipril—type 2 diabetes mellitus	0.0116	0.0648	CrCrCtD
Trandolapril—Fosinopril—Ramipril—type 2 diabetes mellitus	0.0116	0.0648	CrCrCtD
Trandolapril—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0115	0.0679	CbGbCtD
Trandolapril—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0109	0.0648	CbGbCtD
Trandolapril—Aspartame—Nateglinide—type 2 diabetes mellitus	0.00984	0.055	CrCrCtD
Trandolapril—Mitiglinide—Ramipril—type 2 diabetes mellitus	0.00872	0.0487	CrCrCtD
Trandolapril—Moexipril—Ramipril—type 2 diabetes mellitus	0.00872	0.0487	CrCrCtD
Trandolapril—SLC15A2—Glyburide—type 2 diabetes mellitus	0.00858	0.0508	CbGbCtD
Trandolapril—Lisinopril—Ramipril—type 2 diabetes mellitus	0.00753	0.0421	CrCrCtD
Trandolapril—Cilazapril—Ramipril—type 2 diabetes mellitus	0.00753	0.0421	CrCrCtD
Trandolapril—Spirapril—Ramipril—type 2 diabetes mellitus	0.00753	0.0421	CrCrCtD
Trandolapril—SLC15A1—Glyburide—type 2 diabetes mellitus	0.00739	0.0438	CbGbCtD
Trandolapril—Enalapril—Ramipril—type 2 diabetes mellitus	0.00707	0.0395	CrCrCtD
Trandolapril—Nateglinide—Ramipril—type 2 diabetes mellitus	0.0063	0.0352	CrCrCtD
Trandolapril—Aspartame—Ramipril—type 2 diabetes mellitus	0.00598	0.0335	CrCrCtD
Trandolapril—Quinapril—Ramipril—type 2 diabetes mellitus	0.00598	0.0335	CrCrCtD
Trandolapril—Benazepril—Ramipril—type 2 diabetes mellitus	0.0057	0.0319	CrCrCtD
Trandolapril—ACE—arteriole—type 2 diabetes mellitus	0.00238	0.155	CbGeAlD
Trandolapril—ACE—forelimb zeugopod—type 2 diabetes mellitus	0.00208	0.136	CbGeAlD
Trandolapril—ACE—tunica intima—type 2 diabetes mellitus	0.00169	0.11	CbGeAlD
Trandolapril—ACE—sympathetic nervous system—type 2 diabetes mellitus	0.00151	0.0986	CbGeAlD
Trandolapril—CES1—Phase I biotransformations, non P450—PON1—type 2 diabetes mellitus	0.00122	0.136	CbGpPWpGaD
Trandolapril—ACE—autonomic nervous system—type 2 diabetes mellitus	0.00102	0.0663	CbGeAlD
Trandolapril—ACE—hindlimb—type 2 diabetes mellitus	0.000941	0.0613	CbGeAlD
Trandolapril—ACE—peripheral nervous system—type 2 diabetes mellitus	0.000734	0.0478	CbGeAlD
Trandolapril—ACE—artery—type 2 diabetes mellitus	0.000577	0.0376	CbGeAlD
Trandolapril—ACE—nerve—type 2 diabetes mellitus	0.000572	0.0373	CbGeAlD
Trandolapril—CES1—Irinotecan Pathway—ABCC2—type 2 diabetes mellitus	0.000528	0.0585	CbGpPWpGaD
Trandolapril—ACE—endothelium—type 2 diabetes mellitus	0.000487	0.0318	CbGeAlD
Trandolapril—ACE—ACE Inhibitor Pathway—AGTR2—type 2 diabetes mellitus	0.000395	0.0438	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—PCSK2—type 2 diabetes mellitus	0.000385	0.0426	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—CYP3A4—type 2 diabetes mellitus	0.000346	0.0384	CbGpPWpGaD
Trandolapril—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000311	0.0203	CbGeAlD
Trandolapril—CES1—cardiovascular system—type 2 diabetes mellitus	0.000301	0.0196	CbGeAlD
Trandolapril—SLC15A1—kidney—type 2 diabetes mellitus	0.000274	0.0178	CbGeAlD
Trandolapril—CES1—adipose tissue—type 2 diabetes mellitus	0.000266	0.0173	CbGeAlD
Trandolapril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—type 2 diabetes mellitus	0.000225	0.0249	CbGpPWpGaD
Trandolapril—ACE—nephron tubule—type 2 diabetes mellitus	0.000223	0.0145	CbGeAlD
Trandolapril—ACE—ACE Inhibitor Pathway—AGT—type 2 diabetes mellitus	0.000214	0.0237	CbGpPWpGaD
Trandolapril—SLC15A2—retina—type 2 diabetes mellitus	0.000207	0.0135	CbGeAlD
Trandolapril—ACE—cardiovascular system—type 2 diabetes mellitus	0.000201	0.0131	CbGeAlD
Trandolapril—ACE—kidney—type 2 diabetes mellitus	0.000196	0.0128	CbGeAlD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000196	0.0217	CbGpPWpGaD
Trandolapril—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.000195	0.0127	CbGeAlD
Trandolapril—ACE—cortex of kidney—type 2 diabetes mellitus	0.000191	0.0124	CbGeAlD
Trandolapril—CES1—liver—type 2 diabetes mellitus	0.000186	0.0121	CbGeAlD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000182	0.0201	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—DPP4—type 2 diabetes mellitus	0.00018	0.02	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—SLC30A8—type 2 diabetes mellitus	0.00018	0.02	CbGpPWpGaD
Trandolapril—ACE—adipose tissue—type 2 diabetes mellitus	0.000177	0.0115	CbGeAlD
Trandolapril—ACE—Peptide hormone metabolism—GIP—type 2 diabetes mellitus	0.000173	0.0192	CbGpPWpGaD
Trandolapril—SLC15A1—liver—type 2 diabetes mellitus	0.000173	0.0113	CbGeAlD
Trandolapril—SLC15A2—kidney—type 2 diabetes mellitus	0.000171	0.0111	CbGeAlD
Trandolapril—ACE—Peptide hormone metabolism—PCSK1—type 2 diabetes mellitus	0.000167	0.0185	CbGpPWpGaD
Trandolapril—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.000167	0.0109	CbGeAlD
Trandolapril—Mitiglinide—ABCC8—type 2 diabetes mellitus	0.000166	0.132	CrCbGaD
Trandolapril—ACE—ACE Inhibitor Pathway—NOS3—type 2 diabetes mellitus	0.000157	0.0174	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.000136	0.015	CbGpPWpGaD
Trandolapril—ACE—liver—type 2 diabetes mellitus	0.000124	0.00808	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—MTHFR—type 2 diabetes mellitus	0.000121	0.0134	CbGpPWpGaD
Trandolapril—Mitiglinide—KCNJ11—type 2 diabetes mellitus	0.000117	0.0929	CrCbGaD
Trandolapril—ACE—Peptide hormone metabolism—PAX6—type 2 diabetes mellitus	0.000105	0.0116	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—TGFB1—type 2 diabetes mellitus	0.000104	0.0115	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	0.000103	0.0114	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—GHRL—type 2 diabetes mellitus	9.61e-05	0.0107	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—TCF7L2—type 2 diabetes mellitus	8.94e-05	0.00991	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—GCG—type 2 diabetes mellitus	8.79e-05	0.00974	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	8.75e-05	0.00969	CbGpPWpGaD
Trandolapril—Nateglinide—ABCC8—type 2 diabetes mellitus	8.47e-05	0.0671	CrCbGaD
Trandolapril—Fosinopril—ACE—type 2 diabetes mellitus	8.43e-05	0.0668	CrCbGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	8.12e-05	0.00899	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—ABCC2—type 2 diabetes mellitus	8.1e-05	0.00897	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—GNB3—type 2 diabetes mellitus	7.58e-05	0.0084	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—SIRT1—type 2 diabetes mellitus	7.57e-05	0.00839	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PCSK2—type 2 diabetes mellitus	7.26e-05	0.00805	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	7.03e-05	0.00779	CbGpPWpGaD
Trandolapril—Perindopril—ACE—type 2 diabetes mellitus	6.87e-05	0.0545	CrCbGaD
Trandolapril—Spirapril—ACE—type 2 diabetes mellitus	6.8e-05	0.0539	CrCbGaD
Trandolapril—Moexipril—ACE—type 2 diabetes mellitus	6.52e-05	0.0517	CrCbGaD
Trandolapril—Mitiglinide—PPARG—type 2 diabetes mellitus	6.49e-05	0.0515	CrCbGaD
Trandolapril—ACE—Metabolism of proteins—WFS1—type 2 diabetes mellitus	6.47e-05	0.00717	CbGpPWpGaD
Trandolapril—Benazepril—MTHFR—type 2 diabetes mellitus	6.47e-05	0.0512	CrCbGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	6.3e-05	0.00698	CbGpPWpGaD
Trandolapril—Quinapril—ACE—type 2 diabetes mellitus	6.06e-05	0.048	CrCbGaD
Trandolapril—Lisinopril—ACE—type 2 diabetes mellitus	6.06e-05	0.048	CrCbGaD
Trandolapril—Cilazapril—ACE—type 2 diabetes mellitus	6.06e-05	0.048	CrCbGaD
Trandolapril—Nateglinide—KCNJ11—type 2 diabetes mellitus	5.97e-05	0.0473	CrCbGaD
Trandolapril—ACE—Peptide hormone metabolism—AGT—type 2 diabetes mellitus	5.9e-05	0.00654	CbGpPWpGaD
Trandolapril—Ramipril—ACE—type 2 diabetes mellitus	5.87e-05	0.0465	CrCbGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	5.85e-05	0.00648	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.83e-05	0.00647	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—LEP—type 2 diabetes mellitus	5.78e-05	0.00641	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	5.64e-05	0.00624	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	5.44e-05	0.00603	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.42e-05	0.006	CbGpPWpGaD
Trandolapril—Benazepril—ACE—type 2 diabetes mellitus	5.27e-05	0.0418	CrCbGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	5.23e-05	0.0058	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	5.22e-05	0.00578	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—INS—type 2 diabetes mellitus	4.94e-05	0.00548	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—IGF1—type 2 diabetes mellitus	4.78e-05	0.0053	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—SERPINE1—type 2 diabetes mellitus	4.69e-05	0.0052	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	4.59e-05	0.00509	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	4.54e-05	0.00503	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—HMOX1—type 2 diabetes mellitus	4.48e-05	0.00496	CbGpPWpGaD
Trandolapril—Enalapril—ACE—type 2 diabetes mellitus	4.45e-05	0.0352	CrCbGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	4.44e-05	0.00492	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	4.42e-05	0.0049	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CDKN2A—type 2 diabetes mellitus	4.38e-05	0.00485	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	4.26e-05	0.00472	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTM1—type 2 diabetes mellitus	4.17e-05	0.00462	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ADAMTS9—type 2 diabetes mellitus	4.17e-05	0.00462	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	4.12e-05	0.00457	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	4.1e-05	0.00455	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—AGER—type 2 diabetes mellitus	4.02e-05	0.00446	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.76e-05	0.00417	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.63e-05	0.00402	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.49e-05	0.00387	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—DPP4—type 2 diabetes mellitus	3.4e-05	0.00377	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	3.4e-05	0.00377	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.37e-05	0.00373	CbGpPWpGaD
Trandolapril—Nateglinide—PPARG—type 2 diabetes mellitus	3.31e-05	0.0262	CrCbGaD
Trandolapril—ACE—Metabolism of proteins—GIP—type 2 diabetes mellitus	3.27e-05	0.00363	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	3.16e-05	0.0035	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	3.06e-05	0.00339	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	3.02e-05	0.00335	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	2.97e-05	0.00329	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.88e-05	0.0032	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.86e-05	0.00317	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.86e-05	0.00317	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.82e-05	0.00312	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	2.8e-05	0.00311	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	2.75e-05	0.00305	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.68e-05	0.00297	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.66e-05	0.00295	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.66e-05	0.00295	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.62e-05	0.0029	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.61e-05	0.0029	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.43e-05	0.00269	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.34e-05	0.00259	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.33e-05	0.00259	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.33e-05	0.00259	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	2.27e-05	0.00251	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.25e-05	0.00249	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.25e-05	0.00249	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.24e-05	0.00249	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.21e-05	0.00245	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.17e-05	0.00241	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.17e-05	0.0024	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.17e-05	0.0024	CbGpPWpGaD
Trandolapril—Enalapril—CYP3A4—type 2 diabetes mellitus	2.09e-05	0.0166	CrCbGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.09e-05	0.00231	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.09e-05	0.00231	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.08e-05	0.00231	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.05e-05	0.00227	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.04e-05	0.00226	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—F7—type 2 diabetes mellitus	2.04e-05	0.00226	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	1.98e-05	0.0022	CbGpPWpGaD
Trandolapril—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	1.98e-05	0.000398	CcSEcCtD
Trandolapril—Paraesthesia—Valsartan—type 2 diabetes mellitus	1.98e-05	0.000397	CcSEcCtD
Trandolapril—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	1.97e-05	0.000396	CcSEcCtD
Trandolapril—Chest pain—Irbesartan—type 2 diabetes mellitus	1.97e-05	0.000396	CcSEcCtD
Trandolapril—Myalgia—Irbesartan—type 2 diabetes mellitus	1.97e-05	0.000396	CcSEcCtD
Trandolapril—Arthralgia—Irbesartan—type 2 diabetes mellitus	1.97e-05	0.000396	CcSEcCtD
Trandolapril—Shock—Metformin—type 2 diabetes mellitus	1.97e-05	0.000396	CcSEcCtD
Trandolapril—Insomnia—Orlistat—type 2 diabetes mellitus	1.97e-05	0.000395	CcSEcCtD
Trandolapril—Malaise—Losartan—type 2 diabetes mellitus	1.97e-05	0.000395	CcSEcCtD
Trandolapril—Anxiety—Irbesartan—type 2 diabetes mellitus	1.97e-05	0.000395	CcSEcCtD
Trandolapril—Hypersensitivity—Glyburide—type 2 diabetes mellitus	1.97e-05	0.000394	CcSEcCtD
Trandolapril—Nervous system disorder—Metformin—type 2 diabetes mellitus	1.97e-05	0.000394	CcSEcCtD
Trandolapril—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.96e-05	0.000394	CcSEcCtD
Trandolapril—Dyspnoea—Valsartan—type 2 diabetes mellitus	1.96e-05	0.000394	CcSEcCtD
Trandolapril—Vertigo—Losartan—type 2 diabetes mellitus	1.96e-05	0.000393	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	1.96e-05	0.000393	CcSEcCtD
Trandolapril—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	1.96e-05	0.000393	CcSEcCtD
Trandolapril—Somnolence—Valsartan—type 2 diabetes mellitus	1.96e-05	0.000393	CcSEcCtD
Trandolapril—Syncope—Losartan—type 2 diabetes mellitus	1.96e-05	0.000393	CcSEcCtD
Trandolapril—Paraesthesia—Orlistat—type 2 diabetes mellitus	1.95e-05	0.000392	CcSEcCtD
Trandolapril—Leukopenia—Losartan—type 2 diabetes mellitus	1.95e-05	0.000392	CcSEcCtD
Trandolapril—Discomfort—Irbesartan—type 2 diabetes mellitus	1.95e-05	0.000391	CcSEcCtD
Trandolapril—Skin disorder—Metformin—type 2 diabetes mellitus	1.95e-05	0.000391	CcSEcCtD
Trandolapril—Immune system disorder—Ramipril—type 2 diabetes mellitus	1.94e-05	0.000389	CcSEcCtD
Trandolapril—Hyperhidrosis—Metformin—type 2 diabetes mellitus	1.94e-05	0.000389	CcSEcCtD
Trandolapril—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.94e-05	0.000389	CcSEcCtD
Trandolapril—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	1.94e-05	0.000389	CcSEcCtD
Trandolapril—Dizziness—Bromocriptine—type 2 diabetes mellitus	1.93e-05	0.000387	CcSEcCtD
Trandolapril—Dry mouth—Irbesartan—type 2 diabetes mellitus	1.93e-05	0.000387	CcSEcCtD
Trandolapril—Palpitations—Losartan—type 2 diabetes mellitus	1.93e-05	0.000387	CcSEcCtD
Trandolapril—Nausea—Glimepiride—type 2 diabetes mellitus	1.92e-05	0.000386	CcSEcCtD
Trandolapril—Arrhythmia—Ramipril—type 2 diabetes mellitus	1.92e-05	0.000385	CcSEcCtD
Trandolapril—Loss of consciousness—Losartan—type 2 diabetes mellitus	1.92e-05	0.000385	CcSEcCtD
Trandolapril—Nausea—Sitagliptin—type 2 diabetes mellitus	1.92e-05	0.000384	CcSEcCtD
Trandolapril—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.92e-05	0.000384	CcSEcCtD
Trandolapril—Asthenia—Glyburide—type 2 diabetes mellitus	1.91e-05	0.000384	CcSEcCtD
Trandolapril—Decreased appetite—Valsartan—type 2 diabetes mellitus	1.91e-05	0.000384	CcSEcCtD
Trandolapril—Anorexia—Metformin—type 2 diabetes mellitus	1.91e-05	0.000383	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.91e-05	0.00212	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.91e-05	0.00211	CbGpPWpGaD
Trandolapril—Cough—Losartan—type 2 diabetes mellitus	1.9e-05	0.000382	CcSEcCtD
Trandolapril—Urticaria—Gliclazide—type 2 diabetes mellitus	1.9e-05	0.000382	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	1.9e-05	0.000381	CcSEcCtD
Trandolapril—Alopecia—Ramipril—type 2 diabetes mellitus	1.9e-05	0.000381	CcSEcCtD
Trandolapril—Fatigue—Valsartan—type 2 diabetes mellitus	1.9e-05	0.000381	CcSEcCtD
Trandolapril—Abdominal pain—Gliclazide—type 2 diabetes mellitus	1.89e-05	0.00038	CcSEcCtD
Trandolapril—Body temperature increased—Gliclazide—type 2 diabetes mellitus	1.89e-05	0.00038	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.89e-05	0.0021	CbGpPWpGaD
Trandolapril—Oedema—Irbesartan—type 2 diabetes mellitus	1.89e-05	0.00038	CcSEcCtD
Trandolapril—Decreased appetite—Orlistat—type 2 diabetes mellitus	1.89e-05	0.000379	CcSEcCtD
Trandolapril—Pruritus—Glyburide—type 2 diabetes mellitus	1.89e-05	0.000379	CcSEcCtD
Trandolapril—Mental disorder—Ramipril—type 2 diabetes mellitus	1.88e-05	0.000378	CcSEcCtD
Trandolapril—Constipation—Valsartan—type 2 diabetes mellitus	1.88e-05	0.000378	CcSEcCtD
Trandolapril—Infection—Irbesartan—type 2 diabetes mellitus	1.88e-05	0.000377	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	1.88e-05	0.000377	CcSEcCtD
Trandolapril—Fatigue—Orlistat—type 2 diabetes mellitus	1.88e-05	0.000376	CcSEcCtD
Trandolapril—Hypotension—Metformin—type 2 diabetes mellitus	1.87e-05	0.000376	CcSEcCtD
Trandolapril—Malnutrition—Ramipril—type 2 diabetes mellitus	1.87e-05	0.000375	CcSEcCtD
Trandolapril—Shock—Irbesartan—type 2 diabetes mellitus	1.86e-05	0.000373	CcSEcCtD
Trandolapril—Chest pain—Losartan—type 2 diabetes mellitus	1.86e-05	0.000373	CcSEcCtD
Trandolapril—Myalgia—Losartan—type 2 diabetes mellitus	1.86e-05	0.000373	CcSEcCtD
Trandolapril—Arthralgia—Losartan—type 2 diabetes mellitus	1.86e-05	0.000373	CcSEcCtD
Trandolapril—Vomiting—Bromocriptine—type 2 diabetes mellitus	1.86e-05	0.000372	CcSEcCtD
Trandolapril—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	1.86e-05	0.000372	CcSEcCtD
Trandolapril—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.85e-05	0.000372	CcSEcCtD
Trandolapril—Anxiety—Losartan—type 2 diabetes mellitus	1.85e-05	0.000371	CcSEcCtD
Trandolapril—Tachycardia—Irbesartan—type 2 diabetes mellitus	1.85e-05	0.00037	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.85e-05	0.00204	CbGpPWpGaD
Trandolapril—Rash—Bromocriptine—type 2 diabetes mellitus	1.84e-05	0.000369	CcSEcCtD
Trandolapril—Dermatitis—Bromocriptine—type 2 diabetes mellitus	1.84e-05	0.000369	CcSEcCtD
Trandolapril—Skin disorder—Irbesartan—type 2 diabetes mellitus	1.84e-05	0.000369	CcSEcCtD
Trandolapril—Discomfort—Losartan—type 2 diabetes mellitus	1.84e-05	0.000368	CcSEcCtD
Trandolapril—Dysgeusia—Ramipril—type 2 diabetes mellitus	1.83e-05	0.000368	CcSEcCtD
Trandolapril—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	1.83e-05	0.000367	CcSEcCtD
Trandolapril—Headache—Bromocriptine—type 2 diabetes mellitus	1.83e-05	0.000367	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	1.83e-05	0.000366	CcSEcCtD
Trandolapril—Diarrhoea—Glyburide—type 2 diabetes mellitus	1.83e-05	0.000366	CcSEcCtD
Trandolapril—Dry mouth—Losartan—type 2 diabetes mellitus	1.82e-05	0.000364	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	1.82e-05	0.00201	CbGpPWpGaD
Trandolapril—Anorexia—Irbesartan—type 2 diabetes mellitus	1.8e-05	0.000362	CcSEcCtD
Trandolapril—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	1.8e-05	0.000361	CcSEcCtD
Trandolapril—Paraesthesia—Metformin—type 2 diabetes mellitus	1.8e-05	0.000361	CcSEcCtD
Trandolapril—Muscle spasms—Ramipril—type 2 diabetes mellitus	1.8e-05	0.000361	CcSEcCtD
Trandolapril—Feeling abnormal—Orlistat—type 2 diabetes mellitus	1.79e-05	0.00036	CcSEcCtD
Trandolapril—Dyspnoea—Metformin—type 2 diabetes mellitus	1.79e-05	0.000359	CcSEcCtD
Trandolapril—Somnolence—Metformin—type 2 diabetes mellitus	1.78e-05	0.000358	CcSEcCtD
Trandolapril—Oedema—Losartan—type 2 diabetes mellitus	1.78e-05	0.000357	CcSEcCtD
Trandolapril—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	1.78e-05	0.000357	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.77e-05	0.00197	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.77e-05	0.00196	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.77e-05	0.00196	CbGpPWpGaD
Trandolapril—Infection—Losartan—type 2 diabetes mellitus	1.77e-05	0.000355	CcSEcCtD
Trandolapril—Hypotension—Irbesartan—type 2 diabetes mellitus	1.77e-05	0.000355	CcSEcCtD
Trandolapril—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	1.77e-05	0.000354	CcSEcCtD
Trandolapril—Dyspepsia—Metformin—type 2 diabetes mellitus	1.76e-05	0.000354	CcSEcCtD
Trandolapril—Shock—Losartan—type 2 diabetes mellitus	1.75e-05	0.000351	CcSEcCtD
Trandolapril—Urticaria—Valsartan—type 2 diabetes mellitus	1.75e-05	0.000351	CcSEcCtD
Trandolapril—Nervous system disorder—Losartan—type 2 diabetes mellitus	1.75e-05	0.00035	CcSEcCtD
Trandolapril—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.74e-05	0.00035	CcSEcCtD
Trandolapril—Decreased appetite—Metformin—type 2 diabetes mellitus	1.74e-05	0.00035	CcSEcCtD
Trandolapril—Abdominal pain—Valsartan—type 2 diabetes mellitus	1.74e-05	0.000349	CcSEcCtD
Trandolapril—Tachycardia—Losartan—type 2 diabetes mellitus	1.74e-05	0.000349	CcSEcCtD
Trandolapril—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	1.74e-05	0.000348	CcSEcCtD
Trandolapril—Nausea—Bromocriptine—type 2 diabetes mellitus	1.73e-05	0.000348	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	1.73e-05	0.000347	CcSEcCtD
Trandolapril—Fatigue—Metformin—type 2 diabetes mellitus	1.73e-05	0.000347	CcSEcCtD
Trandolapril—Urticaria—Orlistat—type 2 diabetes mellitus	1.73e-05	0.000347	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	1.72e-05	0.000346	CcSEcCtD
Trandolapril—Hyperhidrosis—Losartan—type 2 diabetes mellitus	1.72e-05	0.000345	CcSEcCtD
Trandolapril—Abdominal pain—Orlistat—type 2 diabetes mellitus	1.72e-05	0.000345	CcSEcCtD
Trandolapril—Body temperature increased—Orlistat—type 2 diabetes mellitus	1.72e-05	0.000345	CcSEcCtD
Trandolapril—Asthenia—Gliclazide—type 2 diabetes mellitus	1.72e-05	0.000345	CcSEcCtD
Trandolapril—Agitation—Ramipril—type 2 diabetes mellitus	1.72e-05	0.000345	CcSEcCtD
Trandolapril—Constipation—Metformin—type 2 diabetes mellitus	1.71e-05	0.000344	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.71e-05	0.0019	CbGpPWpGaD
Trandolapril—Angioedema—Ramipril—type 2 diabetes mellitus	1.71e-05	0.000343	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—TGFB1—type 2 diabetes mellitus	1.7e-05	0.00188	CbGpPWpGaD
Trandolapril—Paraesthesia—Irbesartan—type 2 diabetes mellitus	1.7e-05	0.000341	CcSEcCtD
Trandolapril—Anorexia—Losartan—type 2 diabetes mellitus	1.7e-05	0.000341	CcSEcCtD
Trandolapril—Vomiting—Glyburide—type 2 diabetes mellitus	1.7e-05	0.00034	CcSEcCtD
Trandolapril—Pruritus—Gliclazide—type 2 diabetes mellitus	1.7e-05	0.00034	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	1.69e-05	0.00187	CbGpPWpGaD
Trandolapril—Malaise—Ramipril—type 2 diabetes mellitus	1.69e-05	0.000338	CcSEcCtD
Trandolapril—Dyspnoea—Irbesartan—type 2 diabetes mellitus	1.69e-05	0.000338	CcSEcCtD
Trandolapril—Rash—Glyburide—type 2 diabetes mellitus	1.68e-05	0.000338	CcSEcCtD
Trandolapril—Somnolence—Irbesartan—type 2 diabetes mellitus	1.68e-05	0.000337	CcSEcCtD
Trandolapril—Dermatitis—Glyburide—type 2 diabetes mellitus	1.68e-05	0.000337	CcSEcCtD
Trandolapril—Vertigo—Ramipril—type 2 diabetes mellitus	1.68e-05	0.000337	CcSEcCtD
Trandolapril—Syncope—Ramipril—type 2 diabetes mellitus	1.68e-05	0.000337	CcSEcCtD
Trandolapril—Leukopenia—Ramipril—type 2 diabetes mellitus	1.67e-05	0.000336	CcSEcCtD
Trandolapril—Headache—Glyburide—type 2 diabetes mellitus	1.67e-05	0.000335	CcSEcCtD
Trandolapril—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.67e-05	0.000334	CcSEcCtD
Trandolapril—Hypotension—Losartan—type 2 diabetes mellitus	1.66e-05	0.000334	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—GCG—type 2 diabetes mellitus	1.66e-05	0.00184	CbGpPWpGaD
Trandolapril—Palpitations—Ramipril—type 2 diabetes mellitus	1.65e-05	0.000332	CcSEcCtD
Trandolapril—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.65e-05	0.000331	CcSEcCtD
Trandolapril—Decreased appetite—Irbesartan—type 2 diabetes mellitus	1.64e-05	0.00033	CcSEcCtD
Trandolapril—Loss of consciousness—Ramipril—type 2 diabetes mellitus	1.64e-05	0.00033	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.64e-05	0.00182	CbGpPWpGaD
Trandolapril—Diarrhoea—Gliclazide—type 2 diabetes mellitus	1.64e-05	0.000329	CcSEcCtD
Trandolapril—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	1.64e-05	0.000329	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	1.63e-05	0.000328	CcSEcCtD
Trandolapril—Cough—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000328	CcSEcCtD
Trandolapril—Fatigue—Irbesartan—type 2 diabetes mellitus	1.63e-05	0.000327	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	1.62e-05	0.000325	CcSEcCtD
Trandolapril—Hypersensitivity—Valsartan—type 2 diabetes mellitus	1.62e-05	0.000325	CcSEcCtD
Trandolapril—Constipation—Irbesartan—type 2 diabetes mellitus	1.62e-05	0.000325	CcSEcCtD
Trandolapril—Insomnia—Losartan—type 2 diabetes mellitus	1.61e-05	0.000323	CcSEcCtD
Trandolapril—Hypersensitivity—Orlistat—type 2 diabetes mellitus	1.6e-05	0.000322	CcSEcCtD
Trandolapril—Paraesthesia—Losartan—type 2 diabetes mellitus	1.6e-05	0.000321	CcSEcCtD
Trandolapril—Urticaria—Metformin—type 2 diabetes mellitus	1.59e-05	0.00032	CcSEcCtD
Trandolapril—Arthralgia—Ramipril—type 2 diabetes mellitus	1.59e-05	0.00032	CcSEcCtD
Trandolapril—Chest pain—Ramipril—type 2 diabetes mellitus	1.59e-05	0.00032	CcSEcCtD
Trandolapril—Myalgia—Ramipril—type 2 diabetes mellitus	1.59e-05	0.00032	CcSEcCtD
Trandolapril—Dyspnoea—Losartan—type 2 diabetes mellitus	1.59e-05	0.000319	CcSEcCtD
Trandolapril—Anxiety—Ramipril—type 2 diabetes mellitus	1.59e-05	0.000318	CcSEcCtD
Trandolapril—Nausea—Glyburide—type 2 diabetes mellitus	1.59e-05	0.000318	CcSEcCtD
Trandolapril—Abdominal pain—Metformin—type 2 diabetes mellitus	1.59e-05	0.000318	CcSEcCtD
Trandolapril—Dizziness—Gliclazide—type 2 diabetes mellitus	1.58e-05	0.000318	CcSEcCtD
Trandolapril—Somnolence—Losartan—type 2 diabetes mellitus	1.58e-05	0.000318	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	1.58e-05	0.000317	CcSEcCtD
Trandolapril—Asthenia—Valsartan—type 2 diabetes mellitus	1.58e-05	0.000317	CcSEcCtD
Trandolapril—Discomfort—Ramipril—type 2 diabetes mellitus	1.57e-05	0.000316	CcSEcCtD
Trandolapril—Dyspepsia—Losartan—type 2 diabetes mellitus	1.57e-05	0.000314	CcSEcCtD
Trandolapril—Asthenia—Orlistat—type 2 diabetes mellitus	1.56e-05	0.000313	CcSEcCtD
Trandolapril—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.56e-05	0.000313	CcSEcCtD
Trandolapril—Pruritus—Valsartan—type 2 diabetes mellitus	1.56e-05	0.000313	CcSEcCtD
Trandolapril—Dry mouth—Ramipril—type 2 diabetes mellitus	1.56e-05	0.000313	CcSEcCtD
Trandolapril—Decreased appetite—Losartan—type 2 diabetes mellitus	1.55e-05	0.000311	CcSEcCtD
Trandolapril—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	1.55e-05	0.00031	CcSEcCtD
Trandolapril—Pruritus—Orlistat—type 2 diabetes mellitus	1.54e-05	0.000309	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.54e-05	0.0017	CbGpPWpGaD
Trandolapril—Fatigue—Losartan—type 2 diabetes mellitus	1.54e-05	0.000308	CcSEcCtD
Trandolapril—Oedema—Ramipril—type 2 diabetes mellitus	1.53e-05	0.000306	CcSEcCtD
Trandolapril—Vomiting—Gliclazide—type 2 diabetes mellitus	1.52e-05	0.000306	CcSEcCtD
Trandolapril—Constipation—Losartan—type 2 diabetes mellitus	1.52e-05	0.000306	CcSEcCtD
Trandolapril—Rash—Gliclazide—type 2 diabetes mellitus	1.51e-05	0.000303	CcSEcCtD
Trandolapril—Dermatitis—Gliclazide—type 2 diabetes mellitus	1.51e-05	0.000303	CcSEcCtD
Trandolapril—Diarrhoea—Valsartan—type 2 diabetes mellitus	1.51e-05	0.000302	CcSEcCtD
Trandolapril—Urticaria—Irbesartan—type 2 diabetes mellitus	1.5e-05	0.000302	CcSEcCtD
Trandolapril—Shock—Ramipril—type 2 diabetes mellitus	1.5e-05	0.000301	CcSEcCtD
Trandolapril—Headache—Gliclazide—type 2 diabetes mellitus	1.5e-05	0.000301	CcSEcCtD
Trandolapril—Nervous system disorder—Ramipril—type 2 diabetes mellitus	1.5e-05	0.0003	CcSEcCtD
Trandolapril—Abdominal pain—Irbesartan—type 2 diabetes mellitus	1.5e-05	0.0003	CcSEcCtD
Trandolapril—Body temperature increased—Irbesartan—type 2 diabetes mellitus	1.5e-05	0.0003	CcSEcCtD
Trandolapril—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	1.49e-05	0.0003	CcSEcCtD
Trandolapril—Tachycardia—Ramipril—type 2 diabetes mellitus	1.49e-05	0.000299	CcSEcCtD
Trandolapril—Diarrhoea—Orlistat—type 2 diabetes mellitus	1.49e-05	0.000299	CcSEcCtD
Trandolapril—Skin disorder—Ramipril—type 2 diabetes mellitus	1.48e-05	0.000298	CcSEcCtD
Trandolapril—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	1.48e-05	0.000296	CcSEcCtD
Trandolapril—Feeling abnormal—Losartan—type 2 diabetes mellitus	1.47e-05	0.000294	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.47e-05	0.00162	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.47e-05	0.00162	CbGpPWpGaD
Trandolapril—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	1.46e-05	0.000292	CcSEcCtD
Trandolapril—Dizziness—Valsartan—type 2 diabetes mellitus	1.46e-05	0.000292	CcSEcCtD
Trandolapril—Anorexia—Ramipril—type 2 diabetes mellitus	1.46e-05	0.000292	CcSEcCtD
Trandolapril—Dizziness—Orlistat—type 2 diabetes mellitus	1.44e-05	0.000289	CcSEcCtD
Trandolapril—Asthenia—Metformin—type 2 diabetes mellitus	1.44e-05	0.000289	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.43e-05	0.00159	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	1.43e-05	0.00159	CbGpPWpGaD
Trandolapril—Hypotension—Ramipril—type 2 diabetes mellitus	1.43e-05	0.000286	CcSEcCtD
Trandolapril—Nateglinide—CYP3A4—type 2 diabetes mellitus	1.43e-05	0.0113	CrCbGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.43e-05	0.00158	CbGpPWpGaD
Trandolapril—Nausea—Gliclazide—type 2 diabetes mellitus	1.42e-05	0.000286	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.42e-05	0.00158	CbGpPWpGaD
Trandolapril—Pruritus—Metformin—type 2 diabetes mellitus	1.42e-05	0.000285	CcSEcCtD
Trandolapril—Urticaria—Losartan—type 2 diabetes mellitus	1.41e-05	0.000284	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.41e-05	0.00157	CbGpPWpGaD
Trandolapril—Abdominal pain—Losartan—type 2 diabetes mellitus	1.41e-05	0.000282	CcSEcCtD
Trandolapril—Body temperature increased—Losartan—type 2 diabetes mellitus	1.41e-05	0.000282	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	1.41e-05	0.00156	CbGpPWpGaD
Trandolapril—Vomiting—Valsartan—type 2 diabetes mellitus	1.4e-05	0.000281	CcSEcCtD
Trandolapril—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	1.39e-05	0.00028	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	1.39e-05	0.000279	CcSEcCtD
Trandolapril—Rash—Valsartan—type 2 diabetes mellitus	1.39e-05	0.000279	CcSEcCtD
Trandolapril—Dermatitis—Valsartan—type 2 diabetes mellitus	1.39e-05	0.000278	CcSEcCtD
Trandolapril—Vomiting—Orlistat—type 2 diabetes mellitus	1.38e-05	0.000278	CcSEcCtD
Trandolapril—Insomnia—Ramipril—type 2 diabetes mellitus	1.38e-05	0.000277	CcSEcCtD
Trandolapril—Headache—Valsartan—type 2 diabetes mellitus	1.38e-05	0.000277	CcSEcCtD
Trandolapril—Diarrhoea—Metformin—type 2 diabetes mellitus	1.37e-05	0.000275	CcSEcCtD
Trandolapril—Rash—Orlistat—type 2 diabetes mellitus	1.37e-05	0.000275	CcSEcCtD
Trandolapril—Paraesthesia—Ramipril—type 2 diabetes mellitus	1.37e-05	0.000275	CcSEcCtD
Trandolapril—Dermatitis—Orlistat—type 2 diabetes mellitus	1.37e-05	0.000275	CcSEcCtD
Trandolapril—Headache—Orlistat—type 2 diabetes mellitus	1.36e-05	0.000273	CcSEcCtD
Trandolapril—Dyspnoea—Ramipril—type 2 diabetes mellitus	1.36e-05	0.000273	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.36e-05	0.00151	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.36e-05	0.00151	CbGpPWpGaD
Trandolapril—Asthenia—Irbesartan—type 2 diabetes mellitus	1.36e-05	0.000272	CcSEcCtD
Trandolapril—Somnolence—Ramipril—type 2 diabetes mellitus	1.36e-05	0.000272	CcSEcCtD
Trandolapril—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.34e-05	0.00027	CcSEcCtD
Trandolapril—Pruritus—Irbesartan—type 2 diabetes mellitus	1.34e-05	0.000269	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.33e-05	0.00147	CbGpPWpGaD
Trandolapril—Decreased appetite—Ramipril—type 2 diabetes mellitus	1.33e-05	0.000266	CcSEcCtD
Trandolapril—Dizziness—Metformin—type 2 diabetes mellitus	1.33e-05	0.000266	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.32e-05	0.00146	CbGpPWpGaD
Trandolapril—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	1.32e-05	0.000264	CcSEcCtD
Trandolapril—Fatigue—Ramipril—type 2 diabetes mellitus	1.32e-05	0.000264	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.31e-05	0.00145	CbGpPWpGaD
Trandolapril—Hypersensitivity—Losartan—type 2 diabetes mellitus	1.31e-05	0.000263	CcSEcCtD
Trandolapril—Nausea—Valsartan—type 2 diabetes mellitus	1.31e-05	0.000262	CcSEcCtD
Trandolapril—Constipation—Ramipril—type 2 diabetes mellitus	1.31e-05	0.000262	CcSEcCtD
Trandolapril—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.29e-05	0.00026	CcSEcCtD
Trandolapril—Nausea—Orlistat—type 2 diabetes mellitus	1.29e-05	0.000259	CcSEcCtD
Trandolapril—Asthenia—Losartan—type 2 diabetes mellitus	1.28e-05	0.000256	CcSEcCtD
Trandolapril—Vomiting—Metformin—type 2 diabetes mellitus	1.27e-05	0.000256	CcSEcCtD
Trandolapril—Rash—Metformin—type 2 diabetes mellitus	1.26e-05	0.000254	CcSEcCtD
Trandolapril—Dermatitis—Metformin—type 2 diabetes mellitus	1.26e-05	0.000253	CcSEcCtD
Trandolapril—Pruritus—Losartan—type 2 diabetes mellitus	1.26e-05	0.000253	CcSEcCtD
Trandolapril—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.26e-05	0.000252	CcSEcCtD
Trandolapril—Headache—Metformin—type 2 diabetes mellitus	1.26e-05	0.000252	CcSEcCtD
Trandolapril—Dizziness—Irbesartan—type 2 diabetes mellitus	1.25e-05	0.000251	CcSEcCtD
Trandolapril—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.25e-05	0.00025	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.25e-05	0.00138	CbGpPWpGaD
Trandolapril—Nateglinide—ALB—type 2 diabetes mellitus	1.24e-05	0.00986	CrCbGaD
Trandolapril—Diarrhoea—Losartan—type 2 diabetes mellitus	1.22e-05	0.000244	CcSEcCtD
Trandolapril—Urticaria—Ramipril—type 2 diabetes mellitus	1.21e-05	0.000243	CcSEcCtD
Trandolapril—Body temperature increased—Ramipril—type 2 diabetes mellitus	1.21e-05	0.000242	CcSEcCtD
Trandolapril—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.21e-05	0.000242	CcSEcCtD
Trandolapril—Vomiting—Irbesartan—type 2 diabetes mellitus	1.2e-05	0.000241	CcSEcCtD
Trandolapril—Rash—Irbesartan—type 2 diabetes mellitus	1.19e-05	0.000239	CcSEcCtD
Trandolapril—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.19e-05	0.000239	CcSEcCtD
Trandolapril—Nausea—Metformin—type 2 diabetes mellitus	1.19e-05	0.000239	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.19e-05	0.00132	CbGpPWpGaD
Trandolapril—Headache—Irbesartan—type 2 diabetes mellitus	1.19e-05	0.000238	CcSEcCtD
Trandolapril—Dizziness—Losartan—type 2 diabetes mellitus	1.18e-05	0.000236	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.16e-05	0.00128	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.16e-05	0.00128	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.14e-05	0.00126	CbGpPWpGaD
Trandolapril—Vomiting—Losartan—type 2 diabetes mellitus	1.13e-05	0.000227	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	1.13e-05	0.00125	CbGpPWpGaD
Trandolapril—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.12e-05	0.000226	CcSEcCtD
Trandolapril—Nausea—Irbesartan—type 2 diabetes mellitus	1.12e-05	0.000225	CcSEcCtD
Trandolapril—Rash—Losartan—type 2 diabetes mellitus	1.12e-05	0.000225	CcSEcCtD
Trandolapril—Dermatitis—Losartan—type 2 diabetes mellitus	1.12e-05	0.000225	CcSEcCtD
Trandolapril—Headache—Losartan—type 2 diabetes mellitus	1.12e-05	0.000224	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—AGT—type 2 diabetes mellitus	1.11e-05	0.00123	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.1e-05	0.00122	CbGpPWpGaD
Trandolapril—Asthenia—Ramipril—type 2 diabetes mellitus	1.1e-05	0.00022	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—LEP—type 2 diabetes mellitus	1.09e-05	0.00121	CbGpPWpGaD
Trandolapril—Pruritus—Ramipril—type 2 diabetes mellitus	1.08e-05	0.000217	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.07e-05	0.00119	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.06e-05	0.00117	CbGpPWpGaD
Trandolapril—Nausea—Losartan—type 2 diabetes mellitus	1.06e-05	0.000212	CcSEcCtD
Trandolapril—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.04e-05	0.00021	CcSEcCtD
Trandolapril—Dizziness—Ramipril—type 2 diabetes mellitus	1.01e-05	0.000203	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.83e-06	0.00109	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.78e-06	0.00108	CbGpPWpGaD
Trandolapril—Vomiting—Ramipril—type 2 diabetes mellitus	9.71e-06	0.000195	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.69e-06	0.00107	CbGpPWpGaD
Trandolapril—Rash—Ramipril—type 2 diabetes mellitus	9.63e-06	0.000193	CcSEcCtD
Trandolapril—Dermatitis—Ramipril—type 2 diabetes mellitus	9.62e-06	0.000193	CcSEcCtD
Trandolapril—Headache—Ramipril—type 2 diabetes mellitus	9.57e-06	0.000192	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.37e-06	0.00104	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—INS—type 2 diabetes mellitus	9.33e-06	0.00103	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	9.18e-06	0.00102	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.12e-06	0.00101	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.08e-06	0.00101	CbGpPWpGaD
Trandolapril—Nausea—Ramipril—type 2 diabetes mellitus	9.07e-06	0.000182	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	9.02e-06	0.001	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9e-06	0.000997	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.76e-06	0.000971	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.7e-06	0.000964	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.13e-06	0.000901	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.9e-06	0.000876	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.41e-06	0.000821	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.33e-06	0.000813	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.88e-06	0.000762	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.87e-06	0.000651	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.45e-06	0.000604	CbGpPWpGaD
